Tauriga Sciences Inc. to Operate Virtual Exhibitor Booth at the CAMEX 2021 National Association of College Stores Expo on February 22-26, 2021
Tauriga Sciences, Inc. (OTCQB: TAUG) will exhibit virtually at the NACS Campus Store Expo 2021 from February 22-26, showcasing its Tauri-Gum™ product line to North American college bookstores. The NACS, representing a $10 Billion industry, connects nearly 4,000 campuses and 1,000 suppliers. Last year, Tauriga had a main floor exhibit at the same event. Their Tauri-Gum™ is a CBD and CBG infused chewing gum offered in various flavors, and the company also pursues a pharmaceutical initiative targeting nausea regulation for chemotherapy patients.
- Participation in the NACS Campus Store Expo 2021 to showcase Tauri-Gum™ products.
- Established as an Approved Affiliate Vendor of NACS, enhancing credibility.
- Diverse product line with CBD and CBG infused chewing gum, targeting growing health markets.
- None.
The Company is an Approved Affiliate Vendor of The NACS (Vendor ID # 113921)
NEW YORK, NY, Feb. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it will operate a virtual exhibitor booth at the National Association of College Stores (“NACS”) Campus Store Expo 2021 (the “Tradeshow”) on February 22-26, 2021. The Company will showcase its Tauri-Gum™ product line to Buyers from College & University campus bookstores throughout North America. The Company was a main floor exhibit (Booth # 518), last year, at the NACS Campus Store Expo 2020, which took place in New Orleans, Louisiana on the dates February 9-11, 2020.
The National Association of College Stores is the professional trade association of the
The annual NACS Tradeshow attracts more than 22,000 industry stakeholders from around the world. Buyers and sellers come together to conduct business, learn from one another and network. The expo is segmented into six categories: Fuel Equipment & Services, Food Equipment & Foodservice Programs, Candy/Snacks, Facility Development & Store Operations, Merchandise and Technology.
Please see below, the following Credential(s) has been designated to Tauriga Sciences Inc. by the NACS:
Tauriga Sciences, Inc. – NACS Affiliate Vendor ID # 113921
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives. The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment. The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Flavor: Pear Bellini). The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative. This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.
On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)
The Company is headquartered in Wappingers Falls, New York. In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Attachment
FAQ
What is Tauriga Sciences, Inc.'s stock symbol?
When will Tauriga be at the NACS Campus Store Expo 2021?
What products does Tauriga Sciences, Inc. offer?
What is the significance of the NACS for Tauriga?